Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05672277

Enrollment

Registered

2023-01-05

Start date

2023-02-15

Completion date

2024-02-15

Last updated

2023-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Brief summary

The aim of our study is a comparison of the effects of transcutaneous electrical nerve stimulation (TENS) protocols in women with overactive bladder (OAB).

Detailed description

OAB is a condition defined by the International Continence Society as the presence of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology. TENS has positive effects on OAB. However, there are not enough studies on how often this stimulation is applied. Studies are needed on this subject.

Interventions

OTHERTENS 1

Parasacral TENS will be applied for 30 minutes 3 days a week during 6 weeks.

OTHERTENS 2

Parasacral TENS will be applied for 30 minutes one day a week during 6 weeks.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Being in the age range of 18-65 , * Having diagnosed with OAB, * Being a volunteer

Exclusion criteria

* Being pregnant, * presence of severe pelvic organ prolapse, * malignant disease, * urinary infection, * neurological disease, * have electronic and metal implant, * loss of sensation, * lumbosacral peripheral nerve lesion

Design outcomes

Primary

Measure	Time frame	Description
Overactive bladder symptoms	change from baseline at 3 weeks and 6 weeks	Overactive bladder symptoms will be assessed with the Overactive Bladder-V8 Questionnaire

Secondary

Measure	Time frame	Description
Urgency severity	change from baseline at 3 weeks and 6 weeks	Urgency severity will be assessed with Patients' Perception of Intensity of Urgency Scale
Bladder functions	change from baseline at 3 weeks and 6 weeks	Bladder functions will be assessed with voiding diary
Life quality	change from baseline at 3 weeks and 6 weeks	Life quality will be assessed with the King's Health Questionnaire
Strength of pelvic floor muscle	change from baseline at 3 weeks and 6 weeks	Strength of pelvic floor muscle will be assessed with Modified Oxford Scale
Perception of recovery	change from baseline at 3 weeks and 6 weeks	Perception of recovery will be assessed with a 4-point Likert scale

Contacts

Primary ContactSeyda Toprak Celenay

sydtoprak@hotmail.com+90312 906 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026